ArticleFrontiers in immunology2026

Tumor-infiltrating immune cell types predicting recurrence-free survival in melanoma patients receiving adjuvant PD-1 inhibitor therapy.

Andrea Ladányi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.